Urban location, greater percentage of African American residents, and larger facility size are some of the factors linked to the likelihood of COVID‐19 infections in eldercare facilities.
The results are the “best available evidence” that coronavirus infection risk depends on distancing and PPE, say investigators.
Study shows toxic tau protein spreads in brain of older Alzheimer’s patients … Uneven handgrip strength plus weakness may predict rapid cognitive decline … Eli Lilly begins first human tests of a COVID-19 antibody drug … CDC updates infection control guidance for assisted living
Providers struggling to comply with infection control requirements could be looking at fines of up to $20,000 under increased enforcement efforts announced Monday by the Centers for Medicare & Medicaid Services in the wake of the coronavirus pandemic. “We’re ratcheting up penalties with non-compliance to infection control,” CMS Administrator Seema Verma said on a call…
Skilled nursing occupancy levels dropped 132 basis points to 83.4% during the month of March as a result of the COVID-19 pandemic — the lowest since 2012, according to new data released by the National Investment Center for Seniors Housing & Care (NIC). The decrease was the result of more resident transfers from facilities to…
New Jersey Gov. Phil Murphy (D) may be subject to a federal investigation if the state’s top Republican gets his way. GOP State Chairman Doug Steinhardt called on the Justice Department to investigate the governor’s response to long-term care facilities during the coronavirus pandemic, accusing Murphy of mismanaging federal funds for providers, the New Jersey…
Business and operational difficulties continue to vex long-term care providers during the pandemic. To help facilities weather these challenges, McKnight’s will hold an Online Forum on these topics this Thursday. The event will feature two continuing education-approved webinars. The first webinar, to take place at 10:30 a.m. ET, will cover leadership. Steve Fogg, CFO, Marquis…
Researchers have linked higher BMI in diabetes to adverse COVID-19 outcomes in hospitalized patients.
The antiviral drug remdesivir has been shown to improve recovery time in moderate COVID-19 illness, drugmaker Gilead Sciences announced Monday.
First federal count: more than 25,000 coronavirus deaths in nursing homes … AstraZeneca’s heart drug for high-risk patients receives FDA approval … Senior living operator balances safety, quality of life in the COVID-19 era … U.S. hospitals slash hydroxychloroquine use after studies reveal risks, suggest ineffectiveness … CDC: U.S. COVID-19 transmission likely began in January
